CD19 and plasma cell myeloma: As a model, we utilized the RPMI 8226 multiple myeloma cell line, which lacks expression of mesothelin and CD19 (Supplementary Fig. 3a, b) and has moderate expression levels of MUC1 (Fig. 3b).